Where do we stand with mCRPC?
Where do we stand with mCRPC?
Induction chemotherapy added to chemoradiation improves PFS and OS in advanced cervical cancer
Active surveillance for oesophageal cancer shows improved HRQoL compared to standard surgery
Genomic testing: Awareness and effective communication between healthcare professionals and patients
ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC
Locally advanced breast cancer
Looking at radioiodine and other radio-labelled metabolites for thyroid cancers
Early breast cancer: Treatment pattern
Looking at radioiodine and other radio-labelled metabolites for thyroid cancers
Modified radical mastectomy
Cost-benefit analysis of new cancer medicines: The difficult choices of governments
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia